Cargando…

Immunomodulatory Effect of Green Tea Treatment in Combination with Low-dose Chemotherapy in Elderly Acute Myeloid Leukemia Patients with Myelodysplasia-related Changes

Green tea (GT) treatment was evaluated for its effect on the immune and antineoplastic response of elderly acute myeloid leukemia patients with myelodysplasia-related changes (AML-MRC) who are ineligible for aggressive chemotherapy and bone marrow transplants. The eligible patients enrolled in the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calgarotto, Andrana K., Longhini, Ana L., Pericole de Souza, Fernando V., Duarte, Adriana S. Santos, Ferro, Karla P., Santos, Irene, Maso, Victor, Olalla Saad, Sara T., Torello, Cristiane Okuda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995304/ https://www.ncbi.nlm.nih.gov/pubmed/33754891 http://dx.doi.org/10.1177/15347354211002647

Ejemplares similares

Antitumor activities of Quercetin and Green Tea in xenografts of human leukemia HL60 cells
por: Calgarotto, Andrana Karla, et al.
Publicado: (2018)

The polyphenol quercetin induces cell death in leukemia by targeting epigenetic regulators of pro-apoptotic genes
por: Alvarez, Marisa Claudia, et al.
Publicado: (2018)

Polyphenolic Flavonoid Compound Quercetin Effects in the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Torello, Cristiane Okuda, et al.
Publicado: (2021)

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Pericole, Fernando Vieira, et al.
Publicado: (2019)

Immunomodulatory Effects of Green Tea Polyphenols †
por: Wang, Shuzhen, et al.
Publicado: (2021)

TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia
por: Testa, Ugo, et al.
Publicado: (2023)

Evaluation of different protocols for culturing mesenchymal stem cells derived from murine bone marrow
por: Pissarra, Mariana Ferreira, et al.
Publicado: (2022)

The Effects of Green Tea Catechins in Hematological Malignancies
por: Della Via, Fernanda Isabel, et al.
Publicado: (2023)

LEF1‐AS1, long non‐coding RNA, inhibits proliferation in myeloid malignancy
por: Congrains-Castillo, Ada, et al.
Publicado: (2019)

Acute myeloid leukemia with myelodysplasia-related changes and basophilic differentiation
por: Rieu, Jean-Baptiste, et al.
Publicado: (2020)

Differential Effects of Nitrostyrene Derivatives on Myelopoiesis Involve Regulation of C/EBPα and p38MAPK Activity
por: Bartels, Marije, et al.
Publicado: (2014)

Up‐regulation of SPINT2/HAI‐2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion
por: Roversi, Fernanda Marconi, et al.
Publicado: (2018)

(–)-Epigallocatechin-3-gallate induces apoptosis and differentiation in leukaemia by targeting reactive oxygen species and PIN1
por: Della Via, Fernanda Isabel, et al.
Publicado: (2021)

Arhgap21 Deficiency Results in Increase of Osteoblastic Lineage Cells in the Murine Bone Marrow Microenvironment
por: Pissarra, Mariana Ferreira, et al.
Publicado: (2021)

Characterization of Two Homogalacturonan Pectins with Immunomodulatory Activity from Green Tea
por: Wang, Huijun, et al.
Publicado: (2014)

De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
por: Lopes, Matheus Rodrigues, et al.
Publicado: (2017)

Solving the Mystery of Myelodysplasia
por: Radich, Jerald
Publicado: (2008)

Temozolomide-Induced Myelodysplasia
por: Natelson, Ethan A., et al.
Publicado: (2010)

Genetic Characteristics According to Subgroup of Acute Myeloid Leukemia with Myelodysplasia-Related Changes
por: Kang, Dain, et al.
Publicado: (2022)

Screening for myeloid mutations in patients with myelodysplastic syndromes and AML with myelodysplasia-related changes
por: Bezerra, Matheus F., et al.
Publicado: (2022)

Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
por: McCarter, Joseph G. W., et al.
Publicado: (2023)

Acute myeloid leukemia with myelodysplasia-related changes and blasts of the mixed T/myeloid phenotype: a case report
por: Sheng, Xian-Fu, et al.
Publicado: (2022)

CXCR7 participates in CXCL12-mediated migration and homing of leukemic and normal hematopoietic cells
por: Melo, Rita de Cassia Carvalho, et al.
Publicado: (2018)

Novel Non-Coding Transcript in NR4A3 Locus, LncNR4A3, Regulates RNA Processing Machinery Proteins and NR4A3 Expression
por: Congrains, Ada, et al.
Publicado: (2020)

Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC)
por: Arber, Daniel A, et al.
Publicado: (2020)

Antineutrophil cytoplasmic antibodies in myelodysplasia.
por: Hull, D. R., et al.
Publicado: (1996)

Bone Marrow Immunity and Myelodysplasia
por: Lambert, Claude, et al.
Publicado: (2016)

Acquired spherocytosis in the setting of myelodysplasia
por: Karlsson, Linda Katharina, et al.
Publicado: (2022)

Myelodysplasia-Related Features of Acute Myeloid Leukemia Evolving From Philadelphia-Negative Myeloproliferative Neoplasms
por: Kim, Jae-Ryuk, et al.
Publicado: (2016)

Germline heterozygous DDX41 variants in a subset of familial myelodysplasia and acute myeloid leukemia
por: Cardoso, S R, et al.
Publicado: (2016)

Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia‐related changes with megakaryoblastic differentiation
por: Avenoso, Daniele, et al.
Publicado: (2021)

New Insights on Iron Study in Myelodysplasia
por: El Husseiny, Noha M., et al.
Publicado: (2014)

Is Myelodysplasia a Consequence of Normal Aging?
por: Heibl, Sonja, et al.
Publicado: (2021)

PB1977: EVALUATION OF ANTIBODY RESPONSES AMONG FIVE DIFFERENT SARS-COV-2 VACCINES IN CHRONIC MYELOID LEUKEMIA PATIENTS – A REAL-WORLD STUDY
por: Toreli, Ana Carolina, et al.
Publicado: (2023)

Acute Myeloid Leukemia with Myelodysplasia-Related Changes in a Patient with Crohn's Disease Treated with Immunosuppressive Therapy
por: Li, Bowen, et al.
Publicado: (2018)

Acquired Myelodysplasia or Myelodysplastic Syndrome: Clearing the Fog
por: Natelson, Ethan A., et al.
Publicado: (2013)

Myelodysplasia is in the niche: novel concepts and emerging therapies
por: Bulycheva, E, et al.
Publicado: (2015)

Myelodysplasia and Mast Cell Leukemia with t(9;22)
por: Lago, Kathryn J., et al.
Publicado: (2017)

Methotrexate-induced myelodysplasia mimicking myelodysplastic syndrome
por: Kawase, Yuuki, et al.
Publicado: (2018)

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
por: Aujla, Amandeep, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lv3oqbjodr7mfdm8unm331ksn7